APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glycomics & Glycobiology

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.

Selected research

Market Analysis & Forecast

Global Glycomics & Glycobiology Market Analysis and Forecast 2026-2032

26 December 2025197 pages

Choose your research edition.

Industry ResearchGlycomics & Glycobiology Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycomics & Glycobiology Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Glycomics & Glycobiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycomics & Glycobiology Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycomics & Glycobiology Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.

Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.

Read the full market overview

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.

Report Includes

This report presents an overview of global market for Glycomics & Glycobiology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Glycomics & Glycobiology, also provides the revenue of main regions and countries. Of the upcoming market potential for Glycomics & Glycobiology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glycomics & Glycobiology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Glycomics & Glycobiology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Glycomics & Glycobiology revenue, projected growth trends, production technology, application and end-user industry.

Glycomics & Glycobiology Segment by Company

ThermoFisher Scientific

Danaher

Shimadzu Corporation

ProZyme

Takara Bio, Inc.

Agilent Technologies

Bruker

Promega

Waters Corporation

R&D Systems

New England Biolabs

Merck KGaA

Glycomics & Glycobiology Segment by Type

Instruments

Enzymes

Reagents

Kits

Glycomics & Glycobiology Segment by Application

Drug Discovery & Development

Diagnostics

Others

Glycomics & Glycobiology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomics & Glycobiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycomics & Glycobiology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomics & Glycobiology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Glycomics & Glycobiology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Glycomics & Glycobiology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glycomics & Glycobiology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Glycomics & Glycobiology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Instruments Major Player Table 3. Enzymes Major Player Table 4. Reagents Major Player Table 5. Kits Major Player Table 6. Global Glycomics & Glycobiology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Drug Discovery & Development Major Player Table 8. Diagnostics Major Player Table 9. Others Major Player Table 10. Glycomics & Glycobiology Industry Trends Table 11. Glycomics & Glycobiology Industry Drivers Table 12. Glycomics & Glycobiology Industry Opportunities and Challenges Table 13. Glycomics & Glycobiology Industry Restraints Table 14. Global Glycomics & Glycobiology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Glycomics & Glycobiology Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Glycomics & Glycobiology Market Share by Region (2021-2026) Table 17. Global Glycomics & Glycobiology Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Glycomics & Glycobiology Market Share by Region (2027-2032) Table 19. Global Glycomics & Glycobiology Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Glycomics & Glycobiology Revenue Market Share by Players (2021-2026) Table 21. Global Glycomics & Glycobiology Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Glycomics & Glycobiology Key Players Headquarters & Area Served Table 23. Global Glycomics & Glycobiology Players, Product Type & Application Table 24. Global Glycomics & Glycobiology Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Glycomics & Glycobiology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Glycomics & Glycobiology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Glycomics & Glycobiology Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Glycomics & Glycobiology Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Glycomics & Glycobiology Revenue Market Share by Type (2021-2026) Table 31. Global Glycomics & Glycobiology Revenue Market Share by Type (2027-2032) Table 32. Global Glycomics & Glycobiology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Glycomics & Glycobiology Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Glycomics & Glycobiology Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Glycomics & Glycobiology Revenue Market Share by Application (2021-2026) Table 36. Global Glycomics & Glycobiology Revenue Market Share by Application (2027-2032) Table 37. ThermoFisher Scientific Company Information Table 38. ThermoFisher Scientific Business Overview Table 39. ThermoFisher Scientific Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio Table 41. ThermoFisher Scientific Recent Development Table 42. Danaher Company Information Table 43. Danaher Business Overview Table 44. Danaher Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Danaher Glycomics & Glycobiology Product Portfolio Table 46. Danaher Recent Development Table 47. Shimadzu Corporation Company Information Table 48. Shimadzu Corporation Business Overview Table 49. Shimadzu Corporation Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Shimadzu Corporation Glycomics & Glycobiology Product Portfolio Table 51. Shimadzu Corporation Recent Development Table 52. ProZyme Company Information Table 53. ProZyme Business Overview Table 54. ProZyme Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. ProZyme Glycomics & Glycobiology Product Portfolio Table 56. ProZyme Recent Development Table 57. Takara Bio, Inc. Company Information Table 58. Takara Bio, Inc. Business Overview Table 59. Takara Bio, Inc. Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio Table 61. Takara Bio, Inc. Recent Development Table 62. Agilent Technologies Company Information Table 63. Agilent Technologies Business Overview Table 64. Agilent Technologies Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Agilent Technologies Glycomics & Glycobiology Product Portfolio Table 66. Agilent Technologies Recent Development Table 67. Bruker Company Information Table 68. Bruker Business Overview Table 69. Bruker Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bruker Glycomics & Glycobiology Product Portfolio Table 71. Bruker Recent Development Table 72. Promega Company Information Table 73. Promega Business Overview Table 74. Promega Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Promega Glycomics & Glycobiology Product Portfolio Table 76. Promega Recent Development Table 77. Waters Corporation Company Information Table 78. Waters Corporation Business Overview Table 79. Waters Corporation Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Waters Corporation Glycomics & Glycobiology Product Portfolio Table 81. Waters Corporation Recent Development Table 82. R&D Systems Company Information Table 83. R&D Systems Business Overview Table 84. R&D Systems Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. R&D Systems Glycomics & Glycobiology Product Portfolio Table 86. R&D Systems Recent Development Table 87. New England Biolabs Company Information Table 88. New England Biolabs Business Overview Table 89. New England Biolabs Glycomics & Glycobiology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. New England Biolabs Glycomics & Glycobiology Product Portfolio Table 91. New England Biolabs Recent Development Table 92. Merck KGaA Company Information Table 93. Merck KGaA Business Overview Table 94. Merck KGaA Glycomics & Glycobiology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Merck KGaA Glycomics & Glycobiology Product Portfolio Table 96. Merck KGaA Recent Development Table 97. North America Glycomics & Glycobiology Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Glycomics & Glycobiology Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Glycomics & Glycobiology Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Glycomics & Glycobiology Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Glycomics & Glycobiology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Glycomics & Glycobiology Revenue by Country (2021-2026) & (US$ Million) Table 103. North America Glycomics & Glycobiology Revenue by Country (US$ Million) & (2027-2032) Table 104. Europe Glycomics & Glycobiology Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Glycomics & Glycobiology Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Glycomics & Glycobiology Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Glycomics & Glycobiology Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Glycomics & Glycobiology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Glycomics & Glycobiology Revenue by Country (2021-2026) & (US$ Million) Table 110. Europe Glycomics & Glycobiology Revenue by Country (US$ Million) & (2027-2032) Table 111. China Glycomics & Glycobiology Revenue by Type (2021-2026) & (US$ Million) Table 112. China Glycomics & Glycobiology Revenue by Type (2027-2032) & (US$ Million) Table 113. China Glycomics & Glycobiology Revenue by Application (2021-2026) & (US$ Million) Table 114. China Glycomics & Glycobiology Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Glycomics & Glycobiology Revenue by Type (2021-2026) & (US$ Million) Table 116. Asia Glycomics & Glycobiology Revenue by Type (2027-2032) & (US$ Million) Table 117. Asia Glycomics & Glycobiology Revenue by Application (2021-2026) & (US$ Million) Table 118. Asia Glycomics & Glycobiology Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Glycomics & Glycobiology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Glycomics & Glycobiology Revenue by Region (US$ Million) & (2021-2026) Table 121. Asia Glycomics & Glycobiology Revenue by Region (US$ Million) & (2027-2032) Table 122. SAMEA Glycomics & Glycobiology Revenue by Type (2021-2026) & (US$ Million) Table 123. SAMEA Glycomics & Glycobiology Revenue by Type (2027-2032) & (US$ Million) Table 124. SAMEA Glycomics & Glycobiology Revenue by Application (2021-2026) & (US$ Million) Table 125. SAMEA Glycomics & Glycobiology Revenue by Application (2027-2032) & (US$ Million) Table 126. SAMEA Glycomics & Glycobiology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. SAMEA Glycomics & Glycobiology Revenue by Country (2021-2026) & (US$ Million) Table 128. SAMEA Glycomics & Glycobiology Revenue by Country (US$ Million) & (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Glycomics & Glycobiology Image Figure 2. Global Glycomics & Glycobiology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycomics & Glycobiology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Instruments Image Figure 5. Enzymes Image Figure 6. Reagents Image Figure 7. Kits Image Figure 8. Global Glycomics & Glycobiology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Glycomics & Glycobiology Market Size Share 2021 VS 2025 VS 2032 Figure 10. Drug Discovery & Development Image Figure 11. Diagnostics Image Figure 12. Others Image Figure 13. Global Glycomics & Glycobiology Market Size (US$ Million) & (2021-2032) Figure 14. Global Glycomics & Glycobiology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Glycomics & Glycobiology Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Glycomics & Glycobiology Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Glycomics & Glycobiology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Glycomics & Glycobiology Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Glycomics & Glycobiology Revenue Market Share by Type (2021-2032) Figure 21. Global Glycomics & Glycobiology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Glycomics & Glycobiology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Glycomics & Glycobiology Revenue Market Share by Application (2021-2032) Figure 24. North America Glycomics & Glycobiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Glycomics & Glycobiology Revenue Share by Type (2021-2032) Figure 26. North America Glycomics & Glycobiology Revenue Share by Application (2021-2032) Figure 27. North America Glycomics & Glycobiology Revenue Share by Country (2021-2032) Figure 28. United States Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Glycomics & Glycobiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Glycomics & Glycobiology Revenue Share by Type (2021-2032) Figure 33. Europe Glycomics & Glycobiology Revenue Share by Application (2021-2032) Figure 34. Europe Glycomics & Glycobiology Revenue Share by Country (2021-2032) Figure 35. Germany Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Glycomics & Glycobiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Glycomics & Glycobiology Revenue Share by Type (2021-2032) Figure 45. China Glycomics & Glycobiology Revenue Share by Application (2021-2032) Figure 46. Asia Glycomics & Glycobiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Glycomics & Glycobiology Revenue Share by Type (2021-2032) Figure 48. Asia Glycomics & Glycobiology Revenue Share by Application (2021-2032) Figure 49. Asia Glycomics & Glycobiology Revenue Share by Region (2021-2032) Figure 50. Japan Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Glycomics & Glycobiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Glycomics & Glycobiology Revenue Share by Type (2021-2032) Figure 58. SAMEA Glycomics & Glycobiology Revenue Share by Application (2021-2032) Figure 59. SAMEA Glycomics & Glycobiology Revenue Share by Country (2021-2032) Figure 60. Brazil Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Glycomics & Glycobiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Enzymes
  • Reagents
  • Kits
Applications
  • Drug Discovery & Development
  • Diagnostics
  • Others
Companies covered
  • ThermoFisher Scientific
  • Danaher
  • Shimadzu Corporation
  • ProZyme
  • Takara Bio, Inc.
  • Agilent Technologies
  • Bruker
  • Promega
  • Waters Corporation
  • R&D Systems
  • New England Biolabs
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Glycomics & Glycobiology Market by Type
  3. 1.2.1 Global Glycomics & Glycobiology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Instruments
  5. 1.2.3 Enzymes
  6. 1.2.4 Reagents
  7. 1.2.5 Kits
  8. 1.3 Glycomics & Glycobiology Market by Application
  9. 1.3.1 Global Glycomics & Glycobiology Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Drug Discovery & Development
  11. 1.3.3 Diagnostics
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Glycomics & Glycobiology Market Dynamics
  1. 2.1 Glycomics & Glycobiology Industry Trends
  2. 2.2 Glycomics & Glycobiology Industry Drivers
  3. 2.3 Glycomics & Glycobiology Industry Opportunities and Challenges
  4. 2.4 Glycomics & Glycobiology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Glycomics & Glycobiology Market Perspective (2021-2032)
  2. 3.2 Global Glycomics & Glycobiology Growth Trends by Region
  3. 3.2.1 Global Glycomics & Glycobiology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Glycomics & Glycobiology Market Size by Region (2021-2026)
  5. 3.2.3 Global Glycomics & Glycobiology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Glycomics & Glycobiology Revenue by Players
  2. 4.1.1 Global Glycomics & Glycobiology Revenue by Players (2021-2026)
  3. 4.1.2 Global Glycomics & Glycobiology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Glycomics & Glycobiology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Glycomics & Glycobiology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Glycomics & Glycobiology Key Players Headquarters & Area Served
  7. 4.4 Global Glycomics & Glycobiology Players, Product Type & Application
  8. 4.5 Global Glycomics & Glycobiology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Glycomics & Glycobiology Market CR5 and HHI
  11. 4.6.3 2025 Glycomics & Glycobiology Tier 1, Tier 2, and Tier 3
5 Glycomics & Glycobiology Market Size by Type
  1. 5.1 Global Glycomics & Glycobiology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Glycomics & Glycobiology Revenue by Type (2021-2032)
  3. 5.3 Global Glycomics & Glycobiology Revenue Market Share by Type (2021-2032)
6 Glycomics & Glycobiology Market Size by Application
  1. 6.1 Global Glycomics & Glycobiology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Glycomics & Glycobiology Revenue by Application (2021-2032)
  3. 6.3 Global Glycomics & Glycobiology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ThermoFisher Scientific
  2. 7.1.1 ThermoFisher Scientific Company Information
  3. 7.1.2 ThermoFisher Scientific Business Overview
  4. 7.1.3 ThermoFisher Scientific Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio
  6. 7.1.5 ThermoFisher Scientific Recent Developments
  7. 7.2 Danaher
  8. 7.2.1 Danaher Company Information
  9. 7.2.2 Danaher Business Overview
  10. 7.2.3 Danaher Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Danaher Glycomics & Glycobiology Product Portfolio
  12. 7.2.5 Danaher Recent Developments
  13. 7.3 Shimadzu Corporation
  14. 7.3.1 Shimadzu Corporation Company Information
  15. 7.3.2 Shimadzu Corporation Business Overview
  16. 7.3.3 Shimadzu Corporation Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Shimadzu Corporation Glycomics & Glycobiology Product Portfolio
  18. 7.3.5 Shimadzu Corporation Recent Developments
  19. 7.4 ProZyme
  20. 7.4.1 ProZyme Company Information
  21. 7.4.2 ProZyme Business Overview
  22. 7.4.3 ProZyme Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ProZyme Glycomics & Glycobiology Product Portfolio
  24. 7.4.5 ProZyme Recent Developments
  25. 7.5 Takara Bio, Inc.
  26. 7.5.1 Takara Bio, Inc. Company Information
  27. 7.5.2 Takara Bio, Inc. Business Overview
  28. 7.5.3 Takara Bio, Inc. Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio
  30. 7.5.5 Takara Bio, Inc. Recent Developments
  31. 7.6 Agilent Technologies
  32. 7.6.1 Agilent Technologies Company Information
  33. 7.6.2 Agilent Technologies Business Overview
  34. 7.6.3 Agilent Technologies Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Agilent Technologies Glycomics & Glycobiology Product Portfolio
  36. 7.6.5 Agilent Technologies Recent Developments
  37. 7.7 Bruker
  38. 7.7.1 Bruker Company Information
  39. 7.7.2 Bruker Business Overview
  40. 7.7.3 Bruker Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bruker Glycomics & Glycobiology Product Portfolio
  42. 7.7.5 Bruker Recent Developments
  43. 7.8 Promega
  44. 7.8.1 Promega Company Information
  45. 7.8.2 Promega Business Overview
  46. 7.8.3 Promega Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Promega Glycomics & Glycobiology Product Portfolio
  48. 7.8.5 Promega Recent Developments
  49. 7.9 Waters Corporation
  50. 7.9.1 Waters Corporation Company Information
  51. 7.9.2 Waters Corporation Business Overview
  52. 7.9.3 Waters Corporation Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Waters Corporation Glycomics & Glycobiology Product Portfolio
  54. 7.9.5 Waters Corporation Recent Developments
  55. 7.10 R&D Systems
  56. 7.10.1 R&D Systems Company Information
  57. 7.10.2 R&D Systems Business Overview
  58. 7.10.3 R&D Systems Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 R&D Systems Glycomics & Glycobiology Product Portfolio
  60. 7.10.5 R&D Systems Recent Developments
  61. 7.11 New England Biolabs
  62. 7.11.1 New England Biolabs Company Information
  63. 7.11.2 New England Biolabs Business Overview
  64. 7.11.3 New England Biolabs Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  65. 7.11.4 New England Biolabs Glycomics & Glycobiology Product Portfolio
  66. 7.11.5 New England Biolabs Recent Developments
  67. 7.12 Merck KGaA
  68. 7.12.1 Merck KGaA Company Information
  69. 7.12.2 Merck KGaA Business Overview
  70. 7.12.3 Merck KGaA Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Merck KGaA Glycomics & Glycobiology Product Portfolio
  72. 7.12.5 Merck KGaA Recent Developments
8 North America
  1. 8.1 North America Glycomics & Glycobiology Revenue (2021-2032)
  2. 8.2 North America Glycomics & Glycobiology Revenue by Type (2021-2032)
  3. 8.2.1 North America Glycomics & Glycobiology Revenue by Type (2021-2026)
  4. 8.2.2 North America Glycomics & Glycobiology Revenue by Type (2027-2032)
  5. 8.3 North America Glycomics & Glycobiology Revenue Share by Type (2021-2032)
  6. 8.4 North America Glycomics & Glycobiology Revenue by Application (2021-2032)
  7. 8.4.1 North America Glycomics & Glycobiology Revenue by Application (2021-2026)
  8. 8.4.2 North America Glycomics & Glycobiology Revenue by Application (2027-2032)
  9. 8.5 North America Glycomics & Glycobiology Revenue Share by Application (2021-2032)
  10. 8.6 North America Glycomics & Glycobiology Revenue by Country
  11. 8.6.1 North America Glycomics & Glycobiology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Glycomics & Glycobiology Revenue by Country (2021-2026)
  13. 8.6.3 North America Glycomics & Glycobiology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Glycomics & Glycobiology Revenue (2021-2032)
  2. 9.2 Europe Glycomics & Glycobiology Revenue by Type (2021-2032)
  3. 9.2.1 Europe Glycomics & Glycobiology Revenue by Type (2021-2026)
  4. 9.2.2 Europe Glycomics & Glycobiology Revenue by Type (2027-2032)
  5. 9.3 Europe Glycomics & Glycobiology Revenue Share by Type (2021-2032)
  6. 9.4 Europe Glycomics & Glycobiology Revenue by Application (2021-2032)
  7. 9.4.1 Europe Glycomics & Glycobiology Revenue by Application (2021-2026)
  8. 9.4.2 Europe Glycomics & Glycobiology Revenue by Application (2027-2032)
  9. 9.5 Europe Glycomics & Glycobiology Revenue Share by Application (2021-2032)
  10. 9.6 Europe Glycomics & Glycobiology Revenue by Country
  11. 9.6.1 Europe Glycomics & Glycobiology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Glycomics & Glycobiology Revenue by Country (2021-2026)
  13. 9.6.3 Europe Glycomics & Glycobiology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Glycomics & Glycobiology Revenue (2021-2032)
  2. 10.2 China Glycomics & Glycobiology Revenue by Type (2021-2032)
  3. 10.2.1 China Glycomics & Glycobiology Revenue by Type (2021-2026)
  4. 10.2.2 China Glycomics & Glycobiology Revenue by Type (2027-2032)
  5. 10.3 China Glycomics & Glycobiology Revenue Share by Type (2021-2032)
  6. 10.4 China Glycomics & Glycobiology Revenue by Application (2021-2032)
  7. 10.4.1 China Glycomics & Glycobiology Revenue by Application (2021-2026)
  8. 10.4.2 China Glycomics & Glycobiology Revenue by Application (2027-2032)
  9. 10.5 China Glycomics & Glycobiology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Glycomics & Glycobiology Revenue (2021-2032)
  2. 11.2 Asia Glycomics & Glycobiology Revenue by Type (2021-2032)
  3. 11.2.1 Asia Glycomics & Glycobiology Revenue by Type (2021-2026)
  4. 11.2.2 Asia Glycomics & Glycobiology Revenue by Type (2027-2032)
  5. 11.3 Asia Glycomics & Glycobiology Revenue Share by Type (2021-2032)
  6. 11.4 Asia Glycomics & Glycobiology Revenue by Application (2021-2032)
  7. 11.4.1 Asia Glycomics & Glycobiology Revenue by Application (2021-2026)
  8. 11.4.2 Asia Glycomics & Glycobiology Revenue by Application (2027-2032)
  9. 11.5 Asia Glycomics & Glycobiology Revenue Share by Application (2021-2032)
  10. 11.6 Asia Glycomics & Glycobiology Revenue by Country
  11. 11.6.1 Asia Glycomics & Glycobiology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Glycomics & Glycobiology Revenue by Country (2021-2026)
  13. 11.6.3 Asia Glycomics & Glycobiology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Glycomics & Glycobiology Revenue (2021-2032)
  2. 12.2 SAMEA Glycomics & Glycobiology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Glycomics & Glycobiology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Glycomics & Glycobiology Revenue by Type (2027-2032)
  5. 12.3 SAMEA Glycomics & Glycobiology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Glycomics & Glycobiology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Glycomics & Glycobiology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Glycomics & Glycobiology Revenue by Application (2027-2032)
  9. 12.5 SAMEA Glycomics & Glycobiology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Glycomics & Glycobiology Revenue by Country
  11. 12.6.1 SAMEA Glycomics & Glycobiology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Glycomics & Glycobiology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Glycomics & Glycobiology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst